These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 927713)

  • 1. [Medical treatment of cholesterol cholelithiasis using chemodeoxycholic acid in man].
    Barbara L; Roda E; Roda A; Casanova S; Festi D; Sama C; Mazella G; Aldini R
    Minerva Med; 1977 Oct; 68(49):3355-82. PubMed ID: 927713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dissolving of cholesterol gallstones. A current therapeutic problem].
    Erb W
    Med Klin; 1975 Jul; 70(28-29):1199-1207. PubMed ID: 1101004
    [No Abstract]   [Full Text] [Related]  

  • 3. Gallstone formation and dissolution.
    Coyne MJ; Schoenfield LJ
    Prog Liver Dis; 1976; 5():622-35. PubMed ID: 775559
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment.
    Pedersen L; Arnfred T; Thaysen EH
    Scand J Gastroenterol; 1974 Nov; 9(8):787-91. PubMed ID: 4610716
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of chenic acid therapy in patients with cholesterol calculi].
    Roda E; Festi D; Roda A; Sama C; Aldini R; Mazzella G
    Minerva Med; 1977 Sep; 68(43):3027-9. PubMed ID: 909651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of chenodesoxycholic acid in man].
    Rozé C
    Therapie; 1977; 32(4):393-400. PubMed ID: 605418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathophysiological aspects of cholelithiasis].
    Paumgartner G
    Z Gastroenterol Verh; 1976; (9):16-9. PubMed ID: 64077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications, selection criteria and causes of treatment failure in the medical treatment of biliary lithiasis using chenodesoxycholic acid].
    Uscanga L; Wolpert E
    Rev Invest Clin; 1982; 34(4):341-7. PubMed ID: 7170465
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 17. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of patients with gallstones by lecithin.
    Tuzhilin SA; Dreiling DA; Narodetskaja RV; Lukash LK
    Am J Gastroenterol; 1976 Mar; 65(3):231-5. PubMed ID: 937323
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Mechanism of action of chenodeoxycholic acid in gallstone dissolution.
    Northfield TC; Larusso NF; Thistle JL; Hofmann AF
    Gut; 1973 Oct; 14(10):826-7. PubMed ID: 4758693
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and therapy of cholesterol gallstones: with emphasis on the metabolic effects of chenodeoxycholic acid.
    Conley DR; Goldstein LI
    Med Clin North Am; 1975 Jul; 59(4):1025-33. PubMed ID: 1142861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.